-

Shareholder Alert: Robbins LLP Announces a Shareholder Has Sued Guidewire Software, Inc.

SAN DIEGO & SAN MATEO, Calif.--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a purchaser of Guidewire Software Inc. (NASDAQ: GWRE) filed a class action complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between March 6, 2019 and March 4, 2020. Guidewire provides enterprise-level software systems for the property and casualty ("P&C") insurance industry.

If you suffered a loss due to Guidewire's misconduct, click here.

Guidewire Software Inc. (GWRE) Accused of Misleading Shareholders

According to the complaint, throughout the relevant period, Guidewire made false and misleading statements regarding the "robust" demand for its cloud-based products and assured investors that customer demand was "enduring and broad-based across all segments of the market." At the beginning of the class period, cloud sales purportedly represented between 55% - 75% of the Company's totals sales, and by the end of the class period, Guidewire represented the range as between 70% - 80%. Notwithstanding these assurances, demand for Guidewire's cloud products was weak and the Company's transition to the cloud was not going well due to the inferiority of Guidewire's product offerings in comparison with its competitors. Further, Guidewire's transition to the cloud was damaging the Company's traditional on-premises business, as customers delayed purchasing decisions or declined to renew existing licenses. As such, Guidewire's revenue guidance was baseless and unattainable. On March 4, 2020, Guidewire announced its financial results for the second quarter of fiscal 2020, slashing its full year revenue guidance by $57 million. During an earnings conference call, defendants admitted the Company's products needed improvement to meet customer needs and successfully compete against rival systems. Defendants also revealed that Guidewire customers had not transitioned to its cloud products as expected. On this news, Guidewire's share price fell 17%, wiping out over $1.5 billion in market capitalization.

If you purchased shares of Guidewire Software, Inc. (GWRE) between April 8, 2016 and August 13, 2020, you have until September 14, 2020, to ask the court to appoint you lead plaintiff.

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against Baidu settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the FS KKR Capital Corp. Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired FS KKR Capital (NYSE: FSK) securities between May 8, 2024 and February 25, 2026. FS KKR Capital is a private credit firm, also known as Business Development Company, which specializes in making private loans to companies.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.The Allegations: Ro...

Robbins LLP Urges GOSS Stockholders to Contact the Firm for Information About the Class Action Against Gossamer Bio, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Gossamer Bio, Inc. (NASDAQ: GOSS) securities between June 16, 2025 and February 20, 2026. Gossamer is a clinical stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary hypertension (PH) associated with interstitial lung disease.For more information, submit a form, email att...

Robbins LLP Urges IBRX Stockholders to Contact the Firm for Information About the Class Action Against ImmunityBio, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired ImmunityBio, Inc. (NASDAQ: IBRX) securities between January 19, 2026 and March 25, 2026. ImmunityBio is a biotechnology company and ANKTIVA is the Company's lead biologic product. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What is the class period? January 19, 2026 – March 25, 202...
Back to Newsroom